Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Bioavailability of 14C-Labelled Oxytocin
NCT02911480Phase 1Withdrawn
- Sponsor
- Oxytone Bioscience
- Start
- Apr 2016
- Primary completion
- Feb 2017
- Modality
- Peptides
01
Overview
Phase 1, open-label trial of oxytocin in postpartum hemorrhage (PPH) (5 arms), sponsored by Oxytone Bioscience. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Plasma Concentration and 3 more. Planned start Apr 2016; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02911480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02911480.